[1]
S. A. Elsamany, O. Elemam, F. Hassanin, A. Algahami, H. Alghanmi, and K. A. E. A. El naghi, “Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients”, World J Oncol, Aug. 2025, doi: 10.14740/wjon2546.